PRPF3 and lung carcinoma: We suggest that the PRP3, serving as a splicing factor, can be modified by TXNL4B, resulting in promoting G2/M transition, EMT, and DNA repair and contributing to the observed radioresistance of lung cancer through the regulation of FANCI splicing isoforms.